
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
ECCTA is a wide-ranging piece of legislation, addressing a number of issues, but broadly themed around measures to prevent financial crime and to promote transparency in the ownership and use of corporate structures. It contains diverse and unrelated provisions, some of which came into force immediately in December 2023, while others will be brought into force throughout 2024 and into 2025.
Companies and partnerships will need to take steps to address some of what ECCTA brings immediately, while other changes cannot effectively be addressed until they are clarified by secondary legislation or government guidance.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the Economic Crime and Corporate Transparency Act team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

06 August 2026 Publication
On 27 July 2026, BaFin published a Supervisory Communication on money laundering and terrorist financing risks associated with virtual IBAN structures.

06 August 2026 Publication
MAS published a consultation paper proposing amendments to the CIS Code to facilitate greater retail fund product innovation in Singapore.

05 August 2026 Publication
HM Treasury has launched a significant consultation on modernising the UK’s regulatory framework for payment services and electronic money.
.jpg?width=380&width=380&format=webply&auto=webp)
05 August 2026 Publication
This is the latest version of Private Funds View to update private fund managers on the latest relevant, regulatory changes and other key developments.